Fructose-1,6-Diphosphate

HCID 445557CAS 34693-23-7

기본 정보

표준 SMILES: O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O
InChIKey: RNBGYGVWRKECFJ-ZXXMMSQZSA-N
분자식: C6H14O12P2
평균 분자량: 340.12 g/mol

개요

Alpha-D-fructofuranose 1,6-bisphosphate is a D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position. It is functionally related to an alpha-D-fructofuranose. It is a conjugate acid of an alpha-D-fructofuranose 1,6-bisphosphate(4-).

이름 및 식별자

우선 이름: Fructose-1,6-Diphosphate
IUPAC: [(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate

이름 및 동의어

fructose-1,6-diphosphateFructose 1,6-diphosphate[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate((2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl)methyl dihydrogen phosphateSr-FDPRefChem:600595GlyTouCan:G18745STstrontium fructose-1,6-diphosphateG18745STANW5CM3PJ7alpha-D-FosfructofuranoseUNII-ANW5CM3PJ7

이름 더 보기

NSC-575531,6-di-O-phosphono-alpha-D-fructofuranoseCHEMBL1089962alpha-D-Fructofuranose 1,6-diphosphatealpha-D-fructofuranose 1,6-bisphosphatealpha-D-Fructofuranose, 1,6-bis(dihydrogen phosphate)fructose-1,6-bisphosphateAFP

데이터베이스 식별자

CAS: 34693-23-7
PubChem CID: 445557
ChEMBL: CHEMBL1089962
ChEBI: CHEBI:40595
UNII: ANW5CM3PJ7
Nikkaji: J792.775D

물성

구조 계산 물성

XLogP: -5.6
극성 표면적: 203 Å²
수소 결합 공여자 수: 7
수소 결합 수용자 수: 12
회전 가능 결합 수: 6
무거운 원자 수: 20
형식 전하: 0
복잡도: 428

실험 및 물리화학적 성질

Collision Cross Section168.2 Å² [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 4건

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.